Phase Ib study of combinations of avadomide (CC‐122), CC‐223, CC‐292, and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma
Journal article published in 2022 by
Vincent Ribrag 
,
Julio C. Chavez,
Carola Boccomini,
Jason Kaplan,
Jason C. Chandler,
Armando Santoro ,
Paolo Corradini,
Ian W. Flinn,
Ranjana Advani,
Philippe A. Cassier,
Randeep Sangha,
Vaishalee P. Kenkre,
Iris Isufi,
Shailaja Uttamsingh,
Patrick R. Hagner
and other authors.
,
Julio C. Chavez,
Carola Boccomini,
Jason Kaplan,
Jason C. Chandler,
Armando Santoro ,
Paolo Corradini,
Ian W. Flinn,
Ranjana Advani,
Philippe A. Cassier,
Randeep Sangha,
Vaishalee P. Kenkre,
Iris Isufi,
Shailaja Uttamsingh,
Patrick R. Hagner
and other authors.
